- Home
- RGEN vs GTLB Comparison
RGEN vs GTLB Comparison
Compare RGEN & GTLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGEN
- GTLB
- Stock Information
- Founded
- RGEN 1981
- GTLB 2011
- Country
- RGEN United States
- GTLB United States
- Employees
- RGEN N/A
- GTLB N/A
- Industry
- RGEN Medical/Dental Instruments
- GTLB EDP Services
- Sector
- RGEN Health Care
- GTLB Technology
- Exchange
- RGEN Nasdaq
- GTLB Nasdaq
- Market Cap
- RGEN 8.0B
- GTLB 7.0B
- IPO Year
- RGEN N/A
- GTLB 2021
- Fundamental
- Price
- RGEN $131.55
- GTLB $53.36
- Analyst Decision
- RGEN Buy
- GTLB Strong Buy
- Analyst Count
- RGEN 12
- GTLB 23
- Target Price
- RGEN $172.67
- GTLB $71.22
- AVG Volume (30 Days)
- RGEN 847.4K
- GTLB 2.2M
- Earning Date
- RGEN 04-29-2025
- GTLB 06-02-2025
- Dividend Yield
- RGEN N/A
- GTLB N/A
- EPS Growth
- RGEN N/A
- GTLB N/A
- EPS
- RGEN N/A
- GTLB N/A
- Revenue
- RGEN $650,429,000.00
- GTLB $759,249,000.00
- Revenue This Year
- RGEN $13.93
- GTLB $26.19
- Revenue Next Year
- RGEN $14.35
- GTLB $21.91
- P/E Ratio
- RGEN N/A
- GTLB N/A
- Revenue Growth
- RGEN 4.88
- GTLB 30.93
- 52 Week Low
- RGEN $102.97
- GTLB $37.90
- 52 Week High
- RGEN $182.52
- GTLB $74.18
- Technical
- Relative Strength Index (RSI)
- RGEN 47.85
- GTLB 65.91
- Support Level
- RGEN $123.10
- GTLB $44.53
- Resistance Level
- RGEN $143.56
- GTLB $47.41
- Average True Range (ATR)
- RGEN 6.82
- GTLB 1.77
- MACD
- RGEN -0.65
- GTLB 1.13
- Stochastic Oscillator
- RGEN 33.43
- GTLB 97.59
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
About GTLB GitLab Inc.
GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.